✦ LIBER ✦
0170 Phase II trial of neoadjuvant sequential FEC100 followed by docetaxel, carboplatin and trastuzumab (TCH) for HER-2 over-expressing locally advanced breast cancer (LABC): A multi-centre study from British Columbia
✍ Scribed by S. Chia; C. Bryce; G. Pansegrau; N. Macpherson; S. Ellard; D. Jepson; C. Yu; S. Nuraney; A. Attwell; M. Hayes; H. Kennecke; K. Gelmon
- Book ID
- 114316299
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 52 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0960-9776
No coin nor oath required. For personal study only.